RBC Capital Lowers CYH Price Target to $5.00 from $6.00, Maintains "Outperform" Rating
PorAinvest
domingo, 27 de julio de 2025, 5:42 am ET1 min de lectura
CYH--
Based on the one-year price targets offered by 8 analysts, the average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00. This implies an average upside of 28.23% from the current price of $2.90 [1]. The consensus recommendation from 10 brokerage firms indicates a "Hold" status, with an average rating of 2.9 [1]. GuruFocus estimates the GF Value for CYH in one year to be $3.51, suggesting an upside of 21.03% from the current price of $2.9 [1].
CYH reported a 6.5% year-over-year increase in same-store net revenue for the second quarter but experienced a decline in adjusted admissions by 0.7%. Inpatient admissions increased by 0.3%, while same-store surgeries and emergency room visits declined by 2.5% and 1.9%, respectively. The company's adjusted EBITDA was $380 million, down from $387 million in the prior year period, and the EBITDA margin decreased to 12.1% from 12.3% [1].
RBC Capital's updated price target reflects the company's reassessment of CYH's market positioning while still indicating a positive outlook for its performance. The average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00, implying an average upside of 30.25% from the current price of $2.86 [1].
References:
[1] https://www.gurufocus.com/news/3005142/community-health-cyh-price-target-reduced-by-rbc-capital-amid-volume-concerns-cyh-stock-news
RBC Capital maintains "Outperform" rating for CYH but lowers price target from $6.00 to $5.00, representing a 16.67% decrease. The updated price target reflects RBC Capital's reassessment of CYH's market positioning while still indicating a positive outlook for the company's performance. The average target price for Community Health Systems Inc is $3.72 with a high estimate of $5.00 and a low estimate of $3.00, implying an upside of 30.25% from the current price of $2.86.
RBC Capital has revised its price target for Community Health Systems Inc (CYH) from $6.00 to $5.00, while maintaining an "Outperform" rating. The adjustment reflects the firm's concerns over CYH's lower-than-expected adjusted admissions in the second quarter, which has led to a cautious outlook for the remainder of the year. This development adds to existing volume-related worries for the company [1].Based on the one-year price targets offered by 8 analysts, the average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00. This implies an average upside of 28.23% from the current price of $2.90 [1]. The consensus recommendation from 10 brokerage firms indicates a "Hold" status, with an average rating of 2.9 [1]. GuruFocus estimates the GF Value for CYH in one year to be $3.51, suggesting an upside of 21.03% from the current price of $2.9 [1].
CYH reported a 6.5% year-over-year increase in same-store net revenue for the second quarter but experienced a decline in adjusted admissions by 0.7%. Inpatient admissions increased by 0.3%, while same-store surgeries and emergency room visits declined by 2.5% and 1.9%, respectively. The company's adjusted EBITDA was $380 million, down from $387 million in the prior year period, and the EBITDA margin decreased to 12.1% from 12.3% [1].
RBC Capital's updated price target reflects the company's reassessment of CYH's market positioning while still indicating a positive outlook for its performance. The average target price for CYH is $3.72, with a high estimate of $5.00 and a low estimate of $3.00, implying an average upside of 30.25% from the current price of $2.86 [1].
References:
[1] https://www.gurufocus.com/news/3005142/community-health-cyh-price-target-reduced-by-rbc-capital-amid-volume-concerns-cyh-stock-news
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios